Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Morphine Use in the ED and Outcomes of Patients With Acute Heart Failure, A Propensity Score-Matching Analysis Based on the EAHFE Registry

  • Miró, Oscar|||0000-0002-7924-9751
  • Gil, Víctor
  • Martín-Sánchez, Francisco Javier|||0000-0002-5970-725X
  • Herrero-Puente, Pablo|||0000-0002-5529-5008
  • Jacob, Javier|||0000-0003-1101-1066
  • Mebazaa, Alexandre|||0000-0001-8715-7753
  • Harjola, Veli-Pekka
  • Ríos, José|||0000-0002-0716-8784
  • Hollander, Judd E.
  • Peacock, W. Frank
  • Llorens Soriano, Pere|||0000-0002-9291-7179
Objective The objective was to determine the relationship between short-term mortality and intravenous morphine use in ED patients who received a diagnosis of acute heart failure (AHF). Methods Consecutive patients with AHF presenting to 34 Spanish EDs from 2011 to 2014 were eligible for inclusion. The subjects were divided into those with (M) or without IV morphine treatment (WOM) groups during ED stay. The primary outcome was 30-day all-cause mortality, and secondary outcomes were mortality at different intermediate time points, in-hospital mortality, and length of hospital stay. We generated a propensity score to match the M and WOM groups that were 1:1 according to 46 different epidemiological, baseline, clinical, and therapeutic factors. We investigated independent risk factors for 30-day mortality in patients receiving morphine. Results We included 6,516 patients (mean age, 81 [SD, 10] years; 56% women): 416 (6.4%) in the M and 6,100 (93.6%) in the WOM group. Overall, 635 (9.7%; M, 26.7%; WOM, 8.6%) died by day 30. After propensity score matching, 275 paired patients constituted each group. Patients receiving morphine had a higher 30-day mortality (55 [20.0%] vs 35 [12.7%] deaths; hazard ratio, 1.66; 95% CI, 1.09-2.54; P =.017). In patients receiving morphine, death was directly related to glycemia (P =.013) and inversely related to the baseline Barthel index and systolic BP (P =.021) at ED arrival (P =.021). Mortality was increased at every intermediate time point, although the greatest risk was at the shortest time (at 3 days: 22 [8.0%] vs 7 [2.5%] deaths; OR, 3.33; 95% CI, 1.40-7.93; P =.014). In-hospital mortality did not increase (39 [14.2%] vs 26 [9.1%] deaths; OR, 1.65; 95% CI, 0.97-2.82; P =.083) and LOS did not differ between groups (median [interquartile range] in M, 8 [7]; WOM, 8 [6]; P =.79). Conclusions This propensity score-matched analysis suggests that the use of IV morphine in AHF could be associated with increased 30-day mortality.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Timing of previous heart failure hospitalization as a prognostic factor for emergency department heart failure patients

  • Romero, Carlos|||0009-0002-1803-6303
  • Alquézar-Arbé, A.|||0000-0003-4164-274X
  • Herrera, Sergio|||0000-0001-6134-0402
  • Llorens, Pere
  • Gil, Víctor
  • Curtelin, David
  • Jacob, Javier|||0000-0003-1101-1066
  • Herrero-Puente, Pablo|||0000-0002-5529-5008
  • María Pilar Lopez Díez
  • Llauger, Lluis
  • Luisa López Grima, M.
  • Gil, Cristina
  • Tost, Josep|||0000-0003-3846-9616
  • Agüera Urbano, Carmen
  • Espinosa, Begoña
  • Campos-Meneses, Maria
  • Fernandez, G
  • Torres, A.
  • Escoda, Rosa
  • Martín, Enrique
  • Garrido, Jose Manuel
  • Lucas-Imbernon, Francisco Javier
  • Rodríguez-Adrada, Esther
  • Torres Gárate, Raquel|||0000-0002-8731-9350
  • Andueza, Juan Antonio
  • Peacock, W. Frank
  • Miró, Oscar|||0000-0002-7924-9751
To investigate whether the timing of a previous hospital admission for acute heart failure (AHF) is a prognostic factor for AHF patients revisiting the emergency department (ED) in the subsequent 12-month follow-up. All ED AHF patients enrolled in the previously described EAHFE registry were stratified by the presence or absence of an AHF hospitalization admission in the prior 12 months. The primary outcome was 12-month all-cause mortality post ED visit. Secondary end points were hospital admission, prolonged hospitalization (> 7 days), mortality during hospitalization and a 90-day post-discharge adverse composite event (ACE) rate, defined as ED revisits due to AHF, hospitalizations due to AHF, or all-cause mortality. Outcomes were adjusted for baseline and AHF episode characteristics.Of 5,757 patients included, the median age was 84 years (IQR 77-88); 57% were women, and 3,759 (65.3%) had an AHF hospitalization in the previous 12 months. The 12-month mortality was 37% (41.7% vs. 28.3% p < 0.001), hospital admission was 76.1% (78.8% vs. 71.1% p < 0.001) ACE was 60.2% (65.1% vs. 50.5% p < 0.001). In the adjusted analysis, patients with AHF hospitalization in the prior 12 months had a higher mortality (HR = 1.41; 95% CI 1.27-1.56), 90-day ACE rate (HR = 1.45: 95% CI 1.32-1.59), and more hospital admissions (OR = 1.32; 95% CI 1.16-1.51), with shorter times since the previous hospitalization being related to the outcomes analyzed. One-year mortality, adverse events at 90 days, and readmission rates are increased in ED AHF patients previously admitted within the last 12 months.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Tiempo de estancia prolongado en los pacientes ingresados por insuficiencia cardiaca aguda

  • Martín-Sánchez, F.J.
  • Carbajosa, V.
  • Llorens, P.
  • Herrero, P.
  • Jacob, J.
  • Miró, Ò.
  • Fernández, C.
  • Bueno, H.
  • Calvo, E.
  • Ribera Casado, J.M.
  • Adrada, E.R.
  • Lage, M.C.
  • Muñoz, M.
  • Coloma, E.
  • Gil, V.
  • Escoda, R.
  • Pérez-Durá, M.J.
  • Salvo, E.
  • Pavón, J.
  • álvarez, A.B.
  • Noval, A.
  • Torres, J.M.
  • López-Grima, M.L.
  • Valero, A.
  • Juan-Gómez, M.A.
  • Aguirre, A.
  • Pedragosa, M.A.
  • Alonso, M.I.
  • Sancho, H.
  • Ruiz, F.
  • Giménez, A.
  • Franco, J.M.
  • Pardo, S.
  • Mecina, A.B.
  • Rocío, Merino Genicio
  • Tost, J.
  • Penco, B.F.
  • Sánchez, A.L.
  • Fabregat, J.
  • Epelde, F.
  • Sánchez, S.
  • Piñera, P.
  • Garate, R.T.
  • Alquezar, A.
  • Rizzi, M.A.
  • Cabello, I.
  • Richard, F.
  • Lucas, J.
  • álvarez, J.V.
  • Morilla, A.A.
  • Irimia, A.
  • e, Isis Ba
  • Fuentes, M.
  • Gil, C.
Objetivo: Identificar los factores asociados al tiempo de estancia hospitalaria prolongado en pacientes ingresados/as por insuficiencia cardiaca aguda. Método: Estudio observacional de cohorte multipropósito que incluyó pacientes del registro EAHFE (Epidemiology Acute Heart Failure in Emergency) ingresados/as por insuficiencia cardiaca aguda en 25 hospitales españoles. Se recogieron variables demográficas y clínicas, el día y el lugar del ingreso. La variable resultado principal fue el tiempo de estancia hospitalaria mayor que la mediana. Resultados: Se incluyeron 2400 pacientes con una edad media de 79, 5 (±9, 9) años, de los cuales 1334 (55, 6%) eran mujeres. Quinientos noventa (24, 6%) ingresaron en la unidad de corta estancia (UCE), 606 (25, 2%) en cardiología y 1204 (50, 2%) en medicina interna o geriatría. La mediana del tiempo de estancia hospitalaria fue de 7, 0 (intervalo intercuartílico: 4-11 días). Cincuenta y ocho (2, 4%) pacientes fallecieron y 562 (23, 9%) sufrieron un reingreso a los 30 días tras el alta. Los factores independientes asociados a un tiempo de estancia hospitalaria prolongado fueron la enfermedad pulmonar obstructiva crónica, ser portador de un dispositivo, tener un factor precipitante desconocido o no común, la presencia en urgencias de insuficiencia renal, hiponatremia y anemia, no ingresar en una UCE o no disponer de dicha unidad e ingresar un lunes, martes o miércoles; y los asociados a un tiempo de estancia hospitalaria =7 días fueron la hipertensión arterial y tener como factor precipitante una crisis hipertensiva o la falta de adherencia al tratamiento. El área bajo la curva del modelo mixto ajustado al centro fue de 0, 78 (intervalo de confianza del 95%: 0, 76-0, 80; p <0, 001).Conclusiones: Hay una serie de factores asociados con un tiempo de estancia hospitalaria prolongado que deben ser considerados para la gestión del proceso de la insuficiencia cardiaca aguda. Objective: To identify the factors associated with prolonged length of hospital stay in patients admitted for acute heart failure. Methods: Multipurpose observational cohort study including patients from the EAHFE registry admitted for acute heart failure in 25 Spanish hospitals. Data were collected on demographic and clinical variables and on the day and place of admission. The primary outcome was length of hospital stay longer than the median. Results: We included 2, 400 patients with a mean age of 79.5 (9.9) years; of these, 1, 334 (55.6%) were women. Five hundred and ninety (24.6%) were admitted to the short stay unit (SSU), 606 (25.2%) to cardiology, and 1, 204 (50.2%) to internal medicine or gerontology. The mean length of hospital stay was 7.0 (RIC 4-11) days. Fifty-eight (2.4%) patients died and 562 (23.9%) were readmitted within 30 days after discharge. The factors associated with prolonged length of hospital stay were chronic pulmonary disease; being a device carrier; having an unknown or uncommon triggering factor; the presence of renal insufficiency, hyponatremia and anaemia in the emergency department; not being admitted to an SSU or the lack of this facility in the hospital; and being admitted on Monday, Tuesday or Wednesday. The factors associated with length of hospital stay=7days were hypertension, having a hypertensive episode, or a lack of treatment adherence. The area under the curve of the mixed model adjusted to the center was 0.78 (95% CI: 0.76-0.80; p < 0.001). Conclusions: A series of factors is associated with prolonged length of hospital stay and should be taken into account in the management of acute heart failure.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Effects on short term outcome of non-invasive ventilation use in the emergency department to treat patients with acute heart failure: A propensity score-based analysis of the EAHFE Registry

  • Miró, Ò.
  • Martínez, G.
  • Masip, J.
  • Gil, V.
  • Martín-Sánchez, F.J.
  • Llorens, P.
  • Herrero-Puente, P.
  • Sánchez, C.
  • Richard, F.
  • Lucas-Invernón, J.
  • Garrido, J.M.
  • Mebazaa, A.
  • Ríos, J.
  • Peacock, W.F.
  • Hollander, J.E.
  • Jacob, J.
  • Fuentes, M.
  • Gil, C.
  • Alonso, H.
  • Garmila, P.
  • Adrada, E.R.
  • Escoda, R.
  • Xipell, C.
  • Sánchez, C.
  • Gaytan, J.M.
  • Salvo, E.
  • Pérez-Durá, M.J.
  • Noval, A.
  • Torres, J.M.
  • Gómez, M.J.
  • López-Grima, M.L.
  • Valero, A.
  • Aguirre, A.
  • Pedragosa, M.
  • Alonso, M.I.
  • Ruiz, F.
  • Franco, J.M.
  • Diaz, E.
  • Mecina, A.B.
  • Tost, J.
  • Sánchez, S.
  • Piñera, P.
  • Garate, R.T.
  • Alquezar, A.
  • Rizzi, M.A.
  • Herrera, S.
  • Cabello, I.
  • Pérez, J.M.
  • Diez, M.P.L.
  • Alvarez, J.V.
  • Gonzalez, M.S.
  • Román, J.J.G.
  • Carratalá, J.M.
  • Brouzet, B.
  • Marquina, V.
  • Jiménez, I.
  • Hernández, N.
  • Román, F.
  • Andueza, J.A.
  • Romero, R.
  • Calvache, R.
  • Lorca, M.T.
  • Calderón, L.
  • Arriaga, B.A.
  • Sierra, B.
  • Mojarro, E.M.
  • Bécquer, L.T.
  • Garcia, L.L.
  • LaSalle, G.C.
  • Urbano, C.A.
  • Ferrer, E.S.
  • on, behalf, of, the, ICA-SEMES, Research, Group, Researchers
Objective: To assess the effects of non-invasive ventilation (NIV) in emergency department (ED) patients with acute heart failure (AHF) on short term outcomes. Methods: Patients from the EAHFE Registry (a multicenter, observational, multipurpose, cohort-designed database including consecutive AHF patients in 41 Spanish EDs) were grouped based on NIV treatment (NIV+ and NIV–groups). Using propensity score (PS) methodology, we identified two subgroups of patients matched by 38 covariates and compared regarding 30-day survival (primary outcome). Interaction was investigated for age, sex, ischemic cardiomyopathy, chronic obstructive pulmonary disease, AHF precipitated by an acute coronary syndrome (ACS), AHF classified as hypertensive or acute pulmonary edema (APE), and systolic blood pressure (SBP). Secondary outcomes were intensive care unit (ICU) admission; mechanical ventilation; in-hospital, 3-day and 7-day mortality; and prolonged hospitalization (>7 days). Results: Of 11, 152 patients from the EAHFE (age (SD): 80 (10) years; 55.5% women), 718 (6.4%) were NIV+ and had a higher 30-day mortality (HR = 2.229; 95%CI = 1.861–2.670) (p < 0.001). PS matching provided 2 groups of 490 patients each with no significant differences in 30-day mortality (HR = 1.239; 95%CI = 0.905–1.696) (p = 0.182). Interaction analysis suggested a worse effect of NIV on elderly patients (>85 years, p < 0.001), AHF associated with ACS (p = 0.045), and SBP < 100 mmHg (p < 0.001). No significant differences were found in the secondary endpoints except for more prolonged hospitalizations in NIV+ patients (OR = 1.445; 95%CI = 1.122–1.862) (p = 0.004). Conclusion: The use of NIV to treat AHF in ED is not associated with improved mortality outcomes and should be cautious in old patients and those with ACS and hypotension.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Clinical phenotypes of acute heart failure based on signs and symptoms of perfusion and congestion at emergency department presentation and their relationship with patient management and outcomes

  • Javaloyes, P.
  • Miro, O.
  • Gil, V.
  • Martin-Sanchez, F.J.
  • Jacob, J.
  • Herrero, P.
  • Takagi, K.
  • Alquezar-Arbe, A.
  • Diez, M.P.L.
  • Martin, E.
  • Bibiano, C.
  • Escoda, R.
  • Gil, C.
  • Fuentes, M.
  • Garcia, G.L.
  • Perez, J.M.A.
  • Jerez, A.
  • Tost, J.
  • Llauger, L.
  • Romero, R.
  • Garrido, J.M.
  • Rodriguez-Adrada, E.
  • Sanchez, C.
  • Rossello, X.
  • Parissis, J.
  • Mebazaa, A.
  • Chioncel, O.
  • Llorens, P.
  • Alonso, H.
  • Perez-Llantada, E.
  • Cadenas, M.S.
  • Xipell, C.
  • Perez-Dura, M.J.
  • Salvo, E.
  • Pavon, J.
  • Noval, A.
  • Torres, J.M.
  • Lopez-Grima, M.L.
  • Valero, A.
  • Juan, M.A.
  • Aguirre, A.
  • Pedragosa, M.A.
  • Maso, S.M.
  • Alonso, M.I.
  • Ruiz, F.
  • Franco, J.M.
  • Mecina, A.B.
  • Berenguer, M.
  • Donea, R.
  • Ramon, S.S.
  • Rodriguez, V.C.
  • Pinera, P.
  • Nicolas, J.A.S.
  • Garate, R.T.
  • Rizzi, M.A.
  • Herrera, S.
  • Cabello, I.
  • Haro, A.
  • Richard, F.
  • Diez, M.P.L.
  • Alvarez, J.V.
  • Garcia, B.P.
  • Garcia, M.G.
  • Gonzalez, M.S.
  • Marquina, V.
  • Jimenez, I.
  • Hernandez, N.
  • Brouzet, B.
  • Espinosa, B.
  • Andueza, J.A.
  • Ruiz, M.
  • Calvache, R.
  • Serralta, M.T.L.
  • Jave, L.E.C.
  • Amores Arriaga, B.
  • Bergua, B.S.
  • Mojarro, E.M.
  • Jimenez, B.S.A.
  • Becquer, L.T.
  • Burillo, G.
  • Garcia, L.L.
  • LaSalle, G.C.
  • Urbano, C.A.
  • Soto, A.B.G.
  • Padial, E.D.
  • Ferrer, E.S.
  • Lucas-Imbernon, F.J.
  • Gaya, R.
  • Mir, M.
  • Rodriguez, B.
  • Carballo, J.L.
  • Miranda, B.R.
Objective To compare the clinical characteristics and outcomes of patients with acute heart failure (AHF) according to clinical profiles based on congestion and perfusion determined in the emergency department (ED). Methods and results Overall, 11 261 unselected AHF patients from 41 Spanish EDs were classified according to perfusion (normoperfusion = warm; hypoperfusion = cold) and congestion (not = dry; yes = wet). Baseline and decompensation characteristics were recorded as were the main wards to which patients were admitted. The primary outcome was 1-year all-cause mortality; secondary outcomes were need for hospitalisation during the index AHF event, in-hospital all-cause mortality, prolonged hospitalisation, 7-day post-discharge ED revisit for AHF and 30-day post-discharge rehospitalisation for AHF. A total of 8558 patients (76.0%) were warm+ wet, 1929 (17.1%) cold+ wet, 675 (6.0%) warm+ dry, and 99 (0.9%) cold+ dry; hypoperfused (cold) patients were more frequently admitted to intensive care units and geriatrics departments, and warm+ wet patients were discharged home without admission. The four phenotypes differed in most of the baseline and decompensation characteristics. The 1-year mortality was 30.8%, and compared to warm+ dry, the adjusted hazard ratios were significantly increased for cold+ wet (1.660; 95% confidence interval 1.400-1.968) and cold+ dry (1.672; 95% confidence interval 1.189-2.351). Hypoperfused (cold) phenotypes also showed higher rates of index episode hospitalisation and in-hospital mortality, while congestive (wet) phenotypes had a higher risk of prolonged hospitalisation but decreased risk of rehospitalisation. No differences were observed among phenotypes in ED revisit risk. Conclusions Bedside clinical evaluation of congestion and perfusion of AHF patients upon ED arrival and classification according to phenotypic profiles proposed by the latest European Society of Cardiology guidelines provide useful complementary information and help to rapidly predict patient outcomes shortly after ED patient arrival.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Influence of the length of hospitalisation in post-discharge outcomes in patients with acute heart failure: Results of the LOHRCA study

  • Miró, Ò.
  • Padrosa, J.
  • Takagi, K.
  • Gayat, É.
  • Gil, V.
  • Llorens, P.
  • Martín-Sánchez, F.J.
  • Herrero-Puente, P.
  • Jacob, J.
  • Montero, M.M.
  • Tost, J.
  • Díez, M.P.L.
  • Traveria, L.
  • Torres-Gárate, R.
  • Alonso, M.I.
  • Agüera, C.
  • Valero, A.
  • Javaloyes, P.
  • Peacock, W.F.
  • Bueno, H.
  • Mebazaa, A.
  • Fuentes, M.
  • Gil, C.
  • Alonso, H.
  • Garmila, P.
  • García, G.L.
  • Yáñez-Palma, M.C.
  • López, S.I.
  • Escoda, R.
  • Xipell, C.
  • Sánchez, C.
  • Gaytan, J.M.
  • Pérez-Durá, M.J.
  • Salvo, E.
  • Pavón, J.
  • Noval, A.
  • Torres, J.M.
  • López-Grima, M.L.
  • Juan, M.Á.
  • Aguirre, A.
  • Morales, J.E.
  • Masó, S.M.
  • Ruiz, F.
  • Franco, J.M.
  • Mecina, A.B.
  • Sánchez, S.
  • Carbajosa, V.
  • Piñera, P.
  • Nicolás, J.A.S.
  • Garate, R.T.
  • Alquezar, A.
  • Rizzi, M.A.
  • Herrera, S.
  • Roset, A.
  • Cabello, I.
  • Richard, F.
  • Pérez, J.M.Á.
  • Diez, M.P.L.
  • Álvarez, J.V.
  • García, B.P.
  • Sánchez González, M.G.G.Y.
  • Marquina, V.
  • Jiménez, I.
  • Hernández, N.
  • Brouzet, B.
  • Ramos, S.
  • López, A.
  • Andueza, J.A.
  • Romero, R.
  • Ruíz, M.
  • Calvache, R.
  • Lorca, M.T.
  • Calderón, L.
  • Arriaga, B.A.
  • Sierra, B.
  • Mojarro, E.M.
  • Bécquer, L.T.
  • Burillo, G.
  • García, L.L.
  • LaSalle, G.C.
  • Urbano, C.A.
  • Soto, A.B.G.
  • Padial, E.D.
  • Ferrer, E.S.
  • Garrido, M.
  • Lucas, F.J.
  • Gaya, R.
  • Bibiano, C.
  • Mir, M.
  • Rodríguez, B.
  • Sánchez, N.
  • Carballo, J.L.
  • Rodríguez-Adrada, E.
  • Rodríguez, B.
Objective: To investigate the relationship between length of hospitalisation (LOH) and post-discharge outcomes in acute heart failure (AHF) patients and to ascertain whether there are different patterns according to department of initial hospitalisation. Methods: Consecutive AHF patients hospitalised in 41 Spanish centres were grouped based on the LOH (<6/6-10/11-15/>15 days). Outcomes were defined as 90-day post-discharge all-cause mortality, AHF readmissions, and the combination of both. Hazard ratios (HRs), adjusted by chronic conditions and severity of decompensation, were calculated for groups with LOH >6 days vs. LOH <6 days (reference), and stratified by hospitalisation in cardiology, internal medicine, geriatrics, or short-stay units. Results: We included 8563 patients (mean age: 80 (SD = 10) years, 55.5% women), with a median LOH of 7 days (IQR 4–11): 2934 (34.3%) had a LOH <6 days, 3184 (37.2%) 6–10 days, 1287 (15.0%) 11–15 days, and 1158 (13.5%) >15 days. The 90-day post-discharge mortality was 11.4%, readmission 32.2%, and combined endpoint 37.4%. Mortality was increased by 36.5% (95%CI = 13.0–64.9) when LOH was 11–15 days, and by 72.0% (95%CI = 42.6–107.5) when >15 days. Conversely, no differences were found in readmission risk, and the combined endpoint only increased 21.6% (95%CI = 8.4–36.4) for LOH >15 days. Stratified analysis by hospitalisation departments rendered similar post-discharge outcomes, with all exhibiting increased mortality for LOH >15 days and no significant increments in readmission risk. Conclusions: Short hospitalisations are not associated with worse outcomes. While post-discharge readmissions are not affected by LOH, mortality risk increases as the LOH lengthens. These findings were similar across hospitalisation departments.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Outcomes of patients with heart failure with preserved ejection fraction discharged on treatment with neurohormonal antagonists after an episode of decompensation

  • Tost, Josep|||0000-0003-3846-9616
  • Llorens Soriano, Pere|||0000-0002-9291-7179
  • Cotter, Gad|||0000-0002-9613-3339
  • Davison, Beth A.
  • Jacob, Javier|||0000-0003-1101-1066
  • Gil, Víctor
  • Herrero-Puente, Pablo|||0000-0002-5529-5008
  • Martín-Sánchez, Francisco Javier|||0000-0002-5970-725X
  • Donea, Ruxandra
  • Rodríguez, Beatriz|||0000-0002-0402-3838
  • Lucas-Imbernon, Francisco Javier
  • Andueza, Juan Antonio
  • Mecina, Ana Belén
  • Torres Gárate, Raquel|||0000-0002-8731-9350
  • Piñera, Pascual|||0000-0001-9213-9357
  • Alquézar-Arbé, A.|||0000-0003-4164-274X
  • Espinosa, Bego|||0000-0001-9531-6451
  • Mebazaa, A.
  • Chioncel, O.|||0000-0002-3197-3628
  • Miró, Oscar|||0000-0002-7924-9751
Aims: To analyze the frequency with which patients with heart failure with preserved ejection fraction (HFpEF) discharged after an acute heart failure (AHF) episode are treated with antineurohormonal drugs (ANHD), the variables related to ANHD prescription and their relationship with outcomes. Methods: We included consecutive HFpEF patients (left ventricular ejection fraction ≥50%) discharged after an AHF episode from 45 Spanish hospitals whose chronic medications and treatment at discharge were available. Patients were classified according to whether they were discharged with or without ANHD, including beta-blockers (BB), renin-angiotensin-aldosterone-system inhibitors (RAASi) and mineralcorticosteroid-receptor antagonists (MRA). Co-primary outcomes consisted of 1-year all-cause mortality and 90-day combined adverse event (revisit to emergency department -ED-, hospitalization due to AHF or all-cause death). Secondary outcomes were 90-day adverse events taken individually. Adjusted associations of ANHD treatment with outcomes were calculated. Results: We analyzed 3,305 patients with HFpEF (median age: 83, 60% women), 2,312 (70%) discharged with ANHD. The ANHD most frequently prescribed was BB (45.8%). The 1-year mortality was 26.9% (adjusted HR for ANHD patients:1.17, 95%CI=0.98-1.38) and the 90-day combined adverse event was 54.4% (HR=1.14, 95%CI=0.99-1.31). ED revisit was significantly increased by ANHD (HR=1.15, 95%CI=1.01-1.32). MRA and BB were associated with worse results in some co-primary or secondary endpoints, while RAASi (alone) reduced 90-day hospitalization (HR=0.73, 98%CI=0.56-0.96). Conclusion: 70% of HFpEF patients are discharged with ANHD after an AHF episode. ANHD do not seem to reduce mortality or adverse events in HFpEF patients, only RAASi could provide some benefits, reducing the risk of hospitalization for AHF.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Early intravenous nitroglycerin use in prehospital setting and in the emergency department to treat patients with acute heart failure, Insights from the EAHFE Spanish registry

  • Miró, Oscar|||0000-0002-7924-9751
  • Llorens Soriano, Pere|||0000-0002-9291-7179
  • Freund, Yonathan
  • Davison, Beth A.
  • Takagi, Koji
  • Herrero-Puente, Pablo|||0000-0002-5529-5008
  • Jacob, Javier|||0000-0003-1101-1066
  • Martín-Sánchez, Francisco Javier|||0000-0002-5970-725X
  • Gil, Víctor
  • Rossello, Xavier|||0000-0001-6783-8463
  • Alquézar-Arbé, A.|||0000-0003-4164-274X
  • Jiménez-Fábrega, Francesc X.
  • Masip, Josep|||0000-0002-8612-9889
  • Mebazaa, Alexandre|||0000-0001-8715-7753
  • Cotter, Gad|||0000-0002-9613-3339
Background and objective: Although recommended for the treatment of acute heart failure (AHF), the use of intravenous (IV) nitroglycerin (NTG) is supported by scarce and contradicting evidence. In the current analysis, we have assessed the impact of IV NTG administration by EMS or in emergency department (ED) on outcomes of AHF patients. Methods: We analyze AHF patients included by 45 hospitals that were delivered to ED by EMS. Patients were grouped according to whether treatment with IV NTG was started by EMS before ED admission (preED-NTG), during the ED stay (ED-NTG) or were untreated with IV NTG (no-NTG, control group). In-hospital, 30-day and 365-day all-cause mortality, prolonged hospitalization (.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Pronóstico de la insuficiencia cardíaca aguda basado en datos clínicos de congestión, Prognosis of acute heart failure based on clinical data of congestion

  • Espinosa, Bego|||0000-0001-9531-6451
  • Llorens Soriano, Pere|||0000-0002-9291-7179
  • Gil, V.
  • Rossello, X.
  • Jacob, Javier|||0000-0003-1101-1066
  • Herrero-Puente, Pablo|||0000-0002-5529-5008
  • Martín-Sánchez, Francisco Javier|||0000-0002-5970-725X
  • Alquézar-Arbé, A.|||0000-0003-4164-274X
  • Masip, J.
  • Miró, None
Antecedentes y objetivos: Evaluar si los síntomas/signos de congestión en pacientes con insuficiencia cardíaca aguda (ICA) atendidos en los servicios de urgencias hospitalarios (SUH) permiten predecir la evolución a corto plazo. Pacientes y métodos: Pacientes consecutivos diagnosticados de ICA en 45 SUH del registro EAHFE. Recogimos variables clínicas de congestión sistémica (edemas en miembros inferiores, ingurgitación yugular, hepatomegalia) y pulmonar (disnea de esfuerzo, disnea paroxística nocturna, ortopnea y crepitantes pulmonares) analizando su asociación con la mortalidad por cualquier causa a 30 días, de forma cruda y ajustada por diferencias entre grupos. Resultados: Analizamos 18.120 pacientes (mediana = 83 años, rango intercuartil [RIC] = 76-88; mujeres = 55,7%). El 44,6% presentaba., Background and objectives: This work aims to assess whether symptoms/signs of congestion in patients with acute heart failure (AHF) evaluated in hospital emergency departments (HED) allows for predicting short-term progress. Patients and methods: The study group comprised consecutive patients diagnosed with AHF in 45 HED from EAHFE Registry. We collected clinical variables of systemic congestion (edema in the lower extremities, jugular vein distention, hepatomegaly) and pulmonary congestion (dyspnea on exertion, paroxysmal nocturnal dyspnea, orthopnea, and pulmonary crackles) and analyzed their individual and group association with all-cause 30-day of mortality crudely and adjusted for differences between groups. Results: We analyzed 18,120 patients (median=83 years, interquartile range [IQR]=76-88; women=55.7%). Of them, 44.6% had.